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Abstract:  Enhancer elements regulate the tissue- and developmental-stage-specific 
expression of genes. Recent estimates suggest that there are more than 50,000 enhancers in 
mammalian cells. At least a subset of enhancers has been shown to recruit RNA 
polymerase II transcription complexes and to generate enhancer transcripts. Here, we 
provide an overview of enhancer function and discuss how transcription of enhancers or 
enhancer-generated transcripts could contribute to the regulation of gene expression during 
development and differentiation. 
Keywords:  gene regulation; chromatin; transcription factor; noncoding RNA;   
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1. Introduction 
Expression of genes during development and differentiation is regulated by complex mechanisms 
involving many cis-regulatory DNA elements and trans-acting proteins [1,2]. Among the   
cis-regulatory DNA elements modulating transcription of genes are promoters, insulators, enhancers 
and silencers [3±5]. This review will focus on enhancer elements that regulate transcription by RNA 
polymerase II (Pol II) and on the relationship between enhancers and promoters. Promoters are gene 
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proximal regulatory DNA elements that include basal promoter elements [3]. The basal promoter 
associates with general transcription factors that recruit and position RNA polymerase for faithful 
transcription. In contrast to promoters, enhancers are usually located far away from the genes   
they regulate.  
The current estimate for protein coding genes in the mammalian genome ranges from between 
24,000 and 25,000 [2]. A recent map of cis-regulatory DNA elements in the mouse genome suggests 
that the number of enhancers far exceeds the number of genes [6]. Many genes are expressed in 
different cell-types or at different stages during development. Enhancers are often critical for the 
tissue- and developmental-stage-specific expression of genes and collaborate with promoters to fine-
tune the level of expression [5]. Enhancers share many of the hallmarks that characterize promoter 
regions, including DNAse I hypersensitivity, establishment of a nucleosome depleted region (NDR), 
binding of tissue-specific and ubiquitous transcription factors, epigenetic marks that signify accessible 
chromatin and, at least for a subset of enhancers, recruitment of transcription complexes [5]. However, 
there are differences between promoters and enhancers that we shall discuss later.  
2. Enhancer and Locus Control Region (LCR) 
Enhancers were first identified based on their ability to increase transcription of a linked gene in 
transient transfection experiments independent from the orientation of the enhancer with respect to the 
gene they activate [7,8]. Most viral enhancers, tested in mammalian cells, are ubiquitously active, 
whereas enhancers of multicellular organisms generally function in a developmental stage-specific 
and/ or cell-type restricted manner. Like other regulatory DNA elements, enhancers have been 
traditionally identified by DNase I hypersensitivity mapping experiments [9]. Hypersensitive (HS) 
sites that were located in relative proximity to Pol II transcribed genes were sub±cloned into reporter 
constructs and assayed for transcriptional activation using either cell-type specific or ubiquitous 
promoter elements. These early studies revealed functional differences between different HS sites. For 
H[DPSOH VRPH +6 VLWHV DVVRFLDWHG ZLWK WKH KXPDQ ȕ-globin gene locus control region (LCR) 
functioned in stable, but not in transient, transfection experiments, suggesting that a regular chromatin 
environment is important for the function of these elements [10,11]. With respect to overall 
organization principles, enhancers in many ways resemble promoters. They are about 200 to 400 bp in 
size and often harbor a number of transcription factor binding sites that recruit either ubiquitously 
expressed or cell-type-restricted proteins [5]. Enhancers normally do not contain any of the typical Pol 
II basal promoter elements. like TATA-box, initiator (INI) or downstream promoter element (DPE). 
However, there are many promoters that also lack these basal promoter elements, yet are capable of 
recruiting transcription complexes [12]. 
Locus control regions (LCRs) are composite regulatory DNA elements that regulate multiple genes 
LQFRPSOH[JHQHORFL>@/&5VZHUHILUVWGLVFRYHUHGLQWKHKXPDQȕ-globin gene locus and have 
since been identified in many different gene loci. LCRs differ from simple enhancer elements in that 
they are usually composed of multiple HS sites that function together to mediate high-level expression 
of associated genes. LCR associated HS sites can function in an additive, synergistic or in a redundant 
manner [14,15]. Experiments in the growth hormone gene locus revealed that LCR associated HS sites 
harbor specific activities that cooperate in transcription activation [16]. Most genes regulated by LCRs Biology 2012, 1  780 
 
are expressed at extremely high levels in differentiated cells [13]. In contrast to enhancers, the LCR 
DVVRFLDWHGZLWKWKHȕ-globin genes acts in an orientation-dependent manner [17]. 
Figure 1. Comparison of the structure and features of enhancer, as well as housekeeping 
and tissue-specific promoters. Promoters and enhancers are characterized by specific 
chromatin signatures and recruitment of transcription factors as indicated by the symbols, 
which are described in the lower right part. 
 
Recent advances in the analysis of chromatin-associated activities using chromatin 
immunoprecipitation followed by DNA sequencing (ChIP±Seq) or related methods allowed for the 
genome±wide mapping of transcription factor binding and histone tail post-translational modifications 
(PTMs) [18,19]. These studies have revealed that enhancer elements can be distinguished from other 
DNA elements due to a specific combination of histone PTM signatures (Figure 1) [20]. Among these 
signatures is the monomethylation of lysine 4 of histone H3 (H3K4me), which is enriched at enhancer 
elements and, to a lesser degree, at promoters. The trimethylated form of H3K4 (H3K4me3) is 
preferentially associated with promoter regions [21]. The original studies were done with transformed 
cell lines. Recent studies using primary lymphoid cells also showed enrichment of H3K4me3 at 
enhancer elements [22]. Importantly however, the ratio of H3K4me1 versus H3K3me3 was higher at 
enhancers compared to promoters. Nucleosomes flanking enhancer elements are often acetylated at 
H3K27 (H3K27ac) [23,24]. H3K27 is a major substrate for the histone acetyltransferase p300, which 
is also preferentially found at enhancer elements when compared to promoters [18]. In addition to 
histone marks, enhancers are occupied by a specific combination of tissue-restricted and ubiquitous 
transcription factors. Although transcription factors often bind to both promoters and enhancers, some 
proteins preferentially associate with distal regulatory elements. For example, erythroid transcription 
factor NF±E2 and the ubiquitously expressed transcription factor USF2 interact with each other and 
associate with distal enhancer and proximal promoter elements of erythroid specific genes [25,26]. 
TATA, INR, DPE
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Interestingly, a recent analysis of protein chromatin interaction patterns using a high±resolution 
DNAse±I based footprinting assay revealed that NF-E2 directly binds to distal elements and recruits 
USF2 indirectly to these sites; whereas USF2 directly interacts with promoter±proximal sequences and 
indirectly recruits NF±E2 to these sites [27].  
At least a subset of enhancers recruit Pol II transcription complexes, including basal transcription 
factors like TFIIB and TBP [28,29]. Genome-wide RNA sequencing revealed that a large fraction of 
enhancers are transcribed, often in a bidirectional manner [30±32]. The resulting enhancer RNAs 
(eRNAs) appear to be variable in size and may or may not be polyadenylated.  
There is increasing evidence suggesting that different signatures mark poised enhancers versus 
active enhancers. It has been known for a long time that enhancer elements can exhibit DNase I 
hypersensitivity in undifferentiated cells in which the target genes are not active [33]. The binding of 
p300 and the monomethylation of H3K4 of flanking nucleosomes appears to mark poised enhancers, 
while the recruitment of Pol II, the generation of eRNAs and the acetylation of H3K27 is associated 
with active enhancers [18,30]. It is likely that there is not a unique combination of signatures that is 
characteristic for all enhancers. Rather, enhancers likely differ with respect to a specific combination 
of signatures, which will also reflect differences in activity, e.g. chromatin opening versus 
transcription complex recruitment. 
3. Promoter 
The promoter is a DNA segment that recruits RNA polymerase II with the assistance of promoter 
binding proteins. The basal promoter is the minimal sequence required for the recruitment of RNA 
polymerase (Figure 1) [3]. The first isolated mammalian Pol II promoters usually contained a TATA-box 
located 25 to 30bp upstream of the transcription start site. The TATA-box is recognized by the   
TATA-binding protein (TBP) [34]. This interaction is stabilized by transcription factor of Pol II (TFII) 
A and TFIIB [34,35]. TFIIB directly interacts with Pol II and recruits it to the TATA-box protein 
complex. Additional factors required for Pol II transcription are TFIIE, TFIIF and TFIIH. TFIIH is a 
large protein complex that contains ATPase and helicase activity required for melting the DNA for 
transcription initiation. TFII±H also contains kinase activity, which phosphorylates Pol II at the   
C±terminal domain (CTD) at serine 5 (Pol II-ser-5-P). The genome-wide analysis of promoter 
structure revealed that only a minority of Pol II transcribed genes contain a TATA-box. Additional 
basal promoter elements include the initiator (INI) and downstream promoter element (DPE) [36,37]. 
TBP is part of a larger protein complex called TFIID, which also contains TBP associated factors 
(TAFs). Some of the TAFs have been shown to interact with the INI and DPE elements, demonstrating 
that, for many genes, TFIID is the primary DNA binding activity that recruits Pol II to promoters [3]. 
However, there are many Pol II transcribed genes that do not contain any of the known basal promoter 
elements, but often are enriched for GC base pairs. Interestingly, promoters with TATA-box or INI 
elements initiate transcription from very focused sites, whereas GC-rich promoters that do not contain 
basal promoter elements, like those associated with housekeeping genes, are characterized by 
dispersed transcription initiation events (Figure 1) [12]. Interestingly, transcription from focused 
promoters is associated with H3K4me3 and H3K79me1, whereas transcription from GC-rich 
promoters is associated with H4K20me1 and H3K27ac, a mark also associated with enhancer elements [38]. Biology 2012, 1  782 
 
4. Nuclear Transcription Domains 
Transcription in eukaryotes takes place in the nucleus. Certain activities in the nucleus, e.g. rRNA 
synthesis, are compartmentalized. These compartments or domains are not engulfed by membranes, 
but rather represent dynamic centers of specialized function that are characterized by the constant 
influx and efflux of activities that constitute these domains. For example, there is evidence that many 
genes are transcribed in domains enriched for Pol II, referred to as transcription factories [39±41]. It 
appears that transcribed genes associate with transcription factories, while inactive genes do not. 
Furthermore, in erythroid cells, KLF1 co-regulated genes often associate with the same transcription 
factory [42]. How transcription domains are established and how genes are recruited to these sites of 
transcription is currently not known. 
The nucleus is also structured with respect to the separation of inaccessible and accessible 
chromatin. Silent genes are located within inaccessible chromatin territories (CTs), while active genes 
are located at the surface of these territories [43,44]. Chromatin territories are separated from each 
other by the interchromatin compartment (IC), viewed as a laguna-like space in the nucleus that 
contains activities involved in transcription, RNA processing, replication and other functions [43]. The 
CT-IC model predicts that genes have to be relocated from inaccessible internal domains to accessible 
domains on the surface of CTs during activation of transcription. What leads to re-positioning of genes 
away from CTs and anchors them at transcription factories is currently unknown, but enhancers could 
play a role in this process.  
5. Enhancer Function 
Enhancers activate gene expression at the level of transcription [5]. Recent evidence suggests that 
enhancers can be classified with respect to the mechanism by which they increase transcription of 
target genes [5]. The activities range from mediating chromatin opening, positioning of genes with 
respect to transcriptionally active regions in the nucleus, recruitment of transcription complexes, to 
modulating transcription elongation. 
It appears that a distinct set of enhancers act by opening chromatin at promoters to increase 
accessibility for the transcription complex. This has recently been demonstrated for an enhancer 
element associated with embryonic epsilon globin gene expression in thH PXULQH ȕ±globin gene   
locus [45]. The mechanism likely involves the recruitment of chromatin-modifying activities that 
spread from the enhancer to mediate accessibility over nearby promoter regions (Figure 2). Another 
example of enhancer mediated chromatLQDFFHVVLELOLW\VWHPPHG IURPVWXGLHV LQWKHĮ±globin gene 
locus, which revealed that a distantly located enhancer removes polycomb group (PcGs) complexes from 
the globin gene promoters [46]. PcG complexes are involved in transcriptional silencing and   
act by rendering chromatin domains inaccessible [47]. Related to these findings, Taberlay et al. [48] 
demonstrated that the MYOD1 enhancer is in a permissive configuration, marked by a   
nucleosome-depleted region (NDR) and monomethylation of H3K4me1 in undifferentiated cells, while 
the gene it regulates is associated with PcG complexes and H3K27me3, a modification introduced by 
the histone methyltransferase Ezh2, a component of PcGs [47]. During differentiation into muscle 
cells, master regulators (like Myod1 and Oct4) bind the enhancer and recruit activities that ultimately 
remove H3K27me3 and PcG from promoters.  Biology 2012, 1  783 
 
Figure 2. The role of transcription complex recruitment and transcription initiation at 
enhancers. The diagram in the middle depicts a hypothetical gene locus with a gene 
(yellow) regulated by an enhancer element (blue). The nucleosomes (small cylinders) are 
colored dark grey, symbolizing an inaccessible configuration. A transcription complex is 
recruited to the enhancer, and transcription through the enhancer keeps this element in an 
open configuration. Upon differentiation, the enhancer activates transcription of the linked 
gene according to three different scenarios. The mechanism depicted on top shows that 
tracking of the transcription complex along the chromatin fiber reconfigures the chromatin 
and renders the promoter accessible, so that transcription factors and RNA Pol II can be 
recruited to the gene. The model in the lower left indicates that RNA generated from the 
enhancer and RNA generated from the promoter interact and stabilizes interactions 
between promoter and enhancer, which facilitates the transfer of activities from the 
enhancer to the promoter. The model in the lower right indicates that enhancer generated 
transcripts serve as acceptors for repressor proteins and that the removal of the repressors 
allows activation of the promoter. The yellow star represents a DNA binding transcription 
factor. Nucleosomes are represented as light grey (accessible) or dark grey (inaccessible) 
cylinders. RNA polymerase II transcription complexes are represented as pink cylinders. 
The blue and yellow boxes represent enhancers and promoters, respectively. The blue and 
red arrows and lines represent RNAs generated from enhancers (blue) or promoters (red).  
 
Enhancers have been shown to directly recruit transcription complexes, which could be delivered to 
genes by looping mechanisms [29,49,50,51]. A variation of this theme is that enhancers may either 
recruit specific gene loci to preforme transcription factories in the nucleus or actually initiate the 
IRUPDWLRQRIWKHVHGRPDLQV,WZDVVKRZQWKDWWKHȕ±globin genes do not associate with transcription 
factories in erythroid cells in the absence of the LCR [52]. Other studies have shown that enhancers are 
LPSRUWDQWIRUWKHUHODWLYHSRVLWLRQRIJHQHVLQWKHQXFOHXV$JDLQWKHȕ-globin LCR was shown to be 
required for the re-positioning of genes toward the surface of chromatin territories upon activation [53]. Biology 2012, 1  784 
 
There is also increasing evidence demonstrating that enhancer elements affect elongation of RNA 
Pol II by mediating the recruitment of transcription elongation factors like pTEFb or components of 
the FACT (facilitator of chromatin transcription) complex [54±56]. This could be related to the ability 
of enhancers to recruit genes into transcription factories, which may be enriched for these activities. 
Enhancer mediated activation of transcription elongation could play an important role in the activation 
of gene expression during differentiation of embryonic stem cells [56]. Many developmental   
stage±specific genes are repressed in ES cells, but nevertheless were shown to be associated with Pol II 
transcription complexes [57]. Upon differentiation along specific cell lineages, enhancer elements could 
switch on paused Pol II transcription complexes at developmental gene promoters.  
The above described examples illustrate that enhancers are quite diverse with respect to their roles 
in gene activation. For genes regulated by multiple enhancers, each enhancer could provide a unique 
activity, and the collective set of enhancers could therefore mediate optimal gene expression.  
6. Transcription Initiation at Enhancers 
The hitherto clear distinction between promoters and enhancers has become blurry due to recent 
evidence showing that enhancers are capable of recruiting transcription complexes and a recent 
demonstration that promoters can activate other promoters [58,59]. Tuan and colleagues demonstrated 
LQWKDW+6LQWKHKXPDQȕ-globin LCR recruits Pol II transcription complexes, and the authors 
detected long non-coding transcripts downstream of HS2 [60]. These results suggested the possibility 
that Pol II is first recruited to long distance regulatory elements and tracks along the chromatin until it 
is positioned at promoters to generate protein coding mRNAs. A tracking mechanism was supported 
by later studies demonstrating that an insulator placed between the LCR and the genes reduced 
expression of the globin genes and led to accumulation of Pol II at the insulator element [61]. In 
DGGLWLRQ WR +6RWKHU ȕ-globin LCR associated HS sites also recruit Pol II and harbor promoter 
activity [62,63]. Studies by the Paro laboratory showed that transcription through a polycomb   
group responsive element (PRE) in Drosophila switched the element from being silent to being 
activated [64]. The continuous transcription of the PRE element prevented PcG mediated silencing. 
One possible explanation of these results is that the process of transcription erased specific signatures 
at the PRE elements and allowed establishment of a different set of signatures. Transcription mediated 
modification of chromatin structure by Pol II-associated co-regulatory protein complexes has been 
demonstrated for other gene loci as well [65,66]. 
Intronic enhancers have also been shown to recruit transcription complexes, which led investigators 
to propose the term "prohancer" for those enhancer elements that also exhibit promoter activity [67]. A 
recent study by the Higgs laboratory demonstrated that, in fact, many intronic enhancers have 
promoter activity and confer alternative transcription start sites for protein coding genes [68].  
Despite earlier findings of enhancer mediated Pol II recruitment, it was a surprise when in 2010 the 
Greenberg laboratory showed that thousands of neuronal specificity enhancers recruited Pol II and 
initiated formation of enhancer RNAs (eRNAs) [30]. The eRNAs were relatively short and resulted 
from bidirectional transcription initiated in the enhancer elements. Other laboratories have confirmed 
these studies, demonstrating that enhancer mediated recruitment of Pol II is a common event [31,32]. 
A recent investigation into the global nature of eRNAs revealed that most of these RNAs remain in  Biology 2012, 1  785 
 
the nucleus [69]. Furthermore, comparing the results of global high throughput RNA-sequencing 
(RNA-Seq) and of Hi-C, a technique that assays proximity between regulatory elements genome-wide, 
demonstrated that the occurrence of eRNAs correlated with the proximity between enhancers and 
promoters, suggesting that these transcripts are associated with active enhancers [70]. 
7. Possible Functions of eRNAs 
Non-coding RNAs have been shown to associate with protein complexes and to directly regulate 
expression of genes [71]. For example, it was shown that non-coding RNAs associate with PcG 
complexes and silence expression of specific target genes [71]. In this regard, enhancer-associated  
non-coding RNA could serve to tether PcG complexes away from promoters, as outlined in Figure 2. 
Other studies have shown that non-coding RNAs transcribed from HS sites associate with   
co-activators and stimulate transcription of genes [72,73]. Curiously, the non±coding RNAs even 
functioned in transient transfection assays on heterologous promoters despite the fact that in vivo  
they appeared to regulate specific target genes [72]. However, this is also a characteristic of   
some enhancers. 
There are many studies showing that RNAs are involved in the formation of specific protein/ RNA 
complexes or nuclear domains [74]. The ribosome is one example, in which extensive RNA/ RNA and 
RNA/ protein interactions provide the frame-work for protein synthesis. In addition, Shertsov and 
Dundr demonstrated that RNAs are involved in nucleating the formation of nuclear histone bodies in 
the nucleus, which are sites of histone gene transcription [75]. Therefore, the role of many non-coding 
or eRNAs could be to nucleate or stabilize specific nuclear structures, like transcription, replication or 
repair domains. In this respect, it is interesting to note that histones associated with double strand 
breaks are associated with methylated H3K36, a signature of transcribed chromatin [76]. Taking this 
idea a step further, RNA could also be involved in promoting long-range interactions between 
enhancers and promoters (Figure 2). Conventional or non-conventional base-pairing between RNA 
molecules tethered to enhancers and promoters could mediate or stabilize promoter/ enhancer contacts. 
RNA base-pairing-mediated interactions between enhancers and promoters would not only provide 
stability, but also specificity. 
8. Poised Enhancers During Cellular Differentiation  
Different classes of enhancers can be distinguished by their specific epigenetic signatures. Zentner et al. [24] 
reported that active enhancers are either marked by H3K4me1/ H3K27ac or by H3K4me1 and lack 
acetylation of H3K27. Genes that are associated with enhancer containing the H3K27ac mark are 
expressed at higher levels compared to those associated with enhancers that only harbor the H3K4me1 
mark. The authors thus distinguish active from intermediate enhancers based on these different 
modifications and differences in expression levels of associated genes. Poised enhancers are also 
associated with H3K4me1, but lack H3K27ac. Many poised enhancers are associated with H3K27me3 
or H3K9me3, as well as with unstable nucleosomes containing the histone variants H2A.Z and   
H3.3 [24,59]. Interestingly, the active enhancers are characterized by the presence of Pol II, 
phosphorylated at serine 2 and 5 of the CTD, as well as H3K36me3, indicating active transcription at these 
elements [24]. Biology 2012, 1  786 
 
Enhancers are often in a poised configuration in progenitor or stem cells [77]. In fact, many 
enhancers regulating early developmental transcription factor genes are associated with bivalent 
chromatin-containing histone modifications typically associated with active (H3K4me3) or silent 
(H3K27me3) genes in embryonic stem cells [77]. Differentiation of these cells into specific lineages 
leads to the erasure of either the H3K4me3 or the H3K27me3 mark, depending on whether an 
enhancer is active or inactive, respectively. Other enhancers are activated later during differentiation 
and usually associate with so-called pioneer-transcription factors that initiate chromatin remodeling at 
these elements [78]. In general, it appears that the reconfiguration of chromatin structure at enhancers 
precedes the activation of promoters. This is supported by recent findings demonstrating that 
nucleosomes flanking poised enhancers are marked by H3k9me3 [79]. These marks could be bound by 
transcription factors that subsequently activate enhancers [27].  
Observations that enhancers are often primed in progenitor or stem cells suggest that these elements 
are the primary site of recruitment for activities involved in transcription activation, be it activities that 
open chromatin, activities that recruit transcription complexes to target genes or activities that 
stimulate transcription elongation. Moreover, a recent report demonstrated that an enhancer associated 
with the T-cell-specific CD4 gene is required for initiating activation of the gene locus in 
undifferentiated cells that do not express the target gene, but is no longer required in differentiated cells 
that express the CD4 gene [80]. Likewise, DuBose et al. [81] demonstrated that deletion of the SNRPN 
imprinted control region during early embryonic development causes imprinting defects of the 
associated genes; however, deletion of this element in adult brain cells has no effect on imprinted gene 
expression. These studies support a previous finding from the Schaffner laboratory showing that the  
B-cell-specific IgH enhancer is only transiently required for setting up the active state of the target 
gene [82]. Based on these findings, it is possible that enhancers initiate the formation of an active gene 
locus and that epigenetic signatures that are introduced during activation are propagated through 
subsequent differentiation steps. The process of transcription initiated at enhancers could contribute to 
establishing an activated state that is propagated through subsequent cell divisions.  
As mentioned before, recent interaction maps reveal extensive enhancer/ promoter and promoter/ 
promoter interactions [58]. RNAs generated at promoter and enhancer regions could be involved in 
regulating associations between the regulatory elements (Figure 3). It is possible that enhancers and 
eRNAs are involved in setting up transcription domains that are propagated through subsequent cell 
divisions by epigenetic signatures, so that in differentiated cells, promoter/ promoter interactions could 
substitute for enhancer/ promoter interactions [58]. 
9. The Role of Enhancer-Mediated Transcription in Chromatin Modification  
It should be pointed out that the overall level of sequence conservation of non-coding RNA is  
10-fold lower compared to mRNA [31]. Furthermore, it was found that upstream extragenic 
transcription precedes activation of gene transcription, that extragenic transcripts are generated   
at a level 100-fold lower than average gene transcripts and that these extragenic transcripts are   
unstable [31]. Therefore, aside from generating eRNAs, the process of enhancer initiated transcription 
in itself could aide in generating or maintaining an open chromatin configuration during cellular 
differentiation (Figure 2). This could either involve large chromosomal domains or could be restricted Biology 2012, 1  787 
 
to the vicinity of enhancers. Studies in the human growth hormone gene locus demonstrated that 
noncoding transcription, rather than noncoding transcripts, mediate long-range enhancer function [83]. 
Furthermore, enhancer transcription could be involved in introducing the H3K27ac mark, as both of 
these events mark active enhancers. Another possibility is that low level transcription of enhancers in 
undifferentiated cells could maintain a dynamic semi-open state that could be stabilized by increased 
expression of cell-type specific transcription factors in differentiated cells. In this respect, it is 
important to point out that transcription of promoters with dispersed initiation sites often occurs in 
both directions similar to what has been described for enhancer transcription [84]. This divergent 
transcription could aid in shifting nucleosomes away from these regulatory regions. Transcription of 
enhancers could thus facilitate the formation of cell-type specific enhanceosomes [85]. 
Figure 3. Enhancers, promoters and transcription factories. It is proposed that upon 
activation of genes during cellular differentiation, enhancers and promoters come together 
to establish transcription factories. Cell-type specific transcription factors bound at 
promoters and enhancers are involved in mediating proximity between the elements and in 
the recruitment of transcription complexes. RNAs generated from enhancers (blue) and 
promoters (red) stabilize formation of transcription domains.  
 
10. Conclusions 
The recent genome-wide analysis of histone PTMs and transcription factor binding revealed novel 
aspects of long-distance regulatory elements. Enhancers and gene proximal promoters share the ability 
to recruit transcription complexes and to regulate expression of genes over long distances. In hindsight, 
this may not be too surprising, as enhancers and promoters often harbor similar arrangements of 
transcription factor binding sites. However, in contrast to transcription at enhancers, it appears that 
promoter-mediated transcription is more efficient and leads to the production of stable RNAs. The 
reasons for this are currently not known, but may be due to the fact that promoters contain basal 
Promoter
Enhancer
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Differentiation
RNA from Promoter
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promoter elements that recruit Pol II transcription complexes with a high affinity. Furthermore, 
promoters generate transcripts that are conserved and contain sequences that mediate stability. It will 
be important to determine if transcription complex assembly at enhancers follows similar pathways as 
those operating at promoters. Other outstanding questions pertain to the role eRNAs may play during 
activation of transcription and if the process of transcription also contributes to the function of 
enhancers. The available data so far suggest that enhancers exhibit different activities. Therefore, it is 
possible that for those enhancers that are involved in modulating chromatin domains, the process of 
transcription is important, while for those enhancers that modulate the recruitment or activity of 
transcription complexes, the eRNA transcripts directly participate in the activation process.  
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